Professor Clare Turnbull's team is investigating ways to optimise ‘next-generation’ sequencing technologies and analyses of these data in order to identify novel cancer predisposition genes.
Professor Clare Turnbull is a Professor of Translational Cancer Genetics at the ICR and a NHS Consultant in Clinical Cancer Genetics at The Royal Marsden NHS Foundation Trust. Professor Turnbull also works as a Consultant in Public Health Medicine for Public Health England.
Subin is a bioinformatician with a background in computational biology and cancer genomic analysis. She is currently working on web applications and database development for BRCA-Direct project and the CanGene-CanVar programme (CanVar-UK). She obtained her Bachelor's in Biochemical Engineering and Master’s in Cancer with UCL with a thesis on applying machine learning techniques to predict cancer survival.
Dr Alice Garrett is a Clinical Research Fellow/PhD student and a Clinical Genetics trainee. Her current research focusses on breast cancer predisposition and variant interpretation in cancer susceptibility genes on the CRUK-funded CanGene-CanVar programme. She graduated in medicine from the University of Cambridge in 2012 before gaining Membership of the Royal College of Physicians in 2016 and completing an MSc in Medical Education in 2019.
Stephanie is a Programme Administrator in Cancer Genetics at the ICR. Her role spans two current Cancer Research UK (CRUK) funded programs: ‘BRCA-DIRECT’ and ‘CanGene-CanVar’ with the overarching goal to improve the delivery of cancer susceptibility genetics service offered to patients. Stephanie’s involvement includes study administration, logistics coordination, liaising with representatives, and preparing internal and external communications.
Laura is a Pre-Registration Clinical Scientist. Laura’s role involves managing the Cancer Variant Interpretation Group UK (CanVIG-UK) to develop guidelines and resources for the interpretation of cancer susceptibility gene variants.
Chey obtained his PhD in Cancer Genetics from the ICR in 2012 and has a combined ten plus years in the Division of Genetics and Epidemiology, straddling both wet lab and dry lab activities. He is currently working on identifying and characterizing germline determinants of cancer susceptibility, with a particular focus on testicular and breast cancers.
Beth is the Programme Manager for CanGene-CanVar: Data Resources, Clinical and Educational Tools to leverage Cancer Susceptibility Genetics for Early Detection and Prevention of Cancer. Beth has previously worked within NHS R&D and patient advocacy, following completion of her Bachelor’s in Genetics at the University of York and Master’s in Science Communication at the University of Sheffield.